Glitazones (Continued)

• Once daily dosing

• NOT RECOMMENDED if liver disease or elevated liver lab tests (ALT), or severe CHF

• First glitazone (Rezulin) was removed from the market because of rare liver failure leading to death or transplant

Previous slide

Next slide

Back to first slide

View graphic version